IN-VIVO INHIBITION OF VERATRIDINE-EVOKED RELEASE OF STRIATAL EXCITATORY AMINO-ACIDS BY THE GROUP-II METABOTROPIC GLUTAMATE-RECEPTOR AGONISTLY354740 IN RATS
G. Battaglia et al., IN-VIVO INHIBITION OF VERATRIDINE-EVOKED RELEASE OF STRIATAL EXCITATORY AMINO-ACIDS BY THE GROUP-II METABOTROPIC GLUTAMATE-RECEPTOR AGONISTLY354740 IN RATS, Neuroscience letters, 229(3), 1997, pp. 161-164
In vivo microdialysis in freely moving rats was used to investigate th
e presynaptic mechanisms by which LY354740, a novel, potent, selective
, and systemically active agonist for group II metabotropic glutamate
receptors (mGluRs), alters glutamate neuronal transmission. Basal leve
ls of glutamate and aspartate in striatal dialysates of LY354740 (10 m
g/kg i.p.)-treated animals were not significantly different from the s
aline-treated control animals. In the saline treated controls, veratri
dine (100 mu M) induced a 6-fold increase in glutamate and 9-fold incr
ease in aspartate. However, following LY354740 administration the vera
tridine-evoked release of glutamate and aspartate was completely preve
nted. These data demonstrate that LY354740 blocks the evoked release o
f endogenous excitatory amino acids, and indicate a role for group II
mGluRs in presynaptic modulation of glutamate neuronal transmission in
vivo. (C) 1997 Elsevier Science Ireland Ltd.